In this new video, Hayley Yue, Director, Clinical Trial Management and Sophie C., Associate Director, Clinical Trial Management highlight key aspects of our infectious diseases and vaccines clinical operations team in Asia Pacific, who provide clinical trial management oversight for antivirals, antibacterial, antifungals, vaccines, and immunotherapies. With both international experience and country-specific expertise, Medpace experts in Asia Pacific are uniquely equipped to navigate languages, cultures, and clinical environments around the world. Learn more about Medpace's clinical development capabilities in #InfectiousDiseases and #Vaccines: https://lnkd.in/g-Z8FfPd
Medpace
Pharmaceutical Manufacturing
Cincinnati, OH 236,190 followers
Accelerating Drug, Biologic and Medical Device Clinical Development
Über uns
Medpace is a scientifically-driven, global, full-service clinical contract research organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace’s mission is to accelerate the global development of safe and effective medical therapeutics through its high-science and disciplined operating approach that leverages local regulatory and deep therapeutic expertise across all major areas including oncology, cardiology, metabolic disease, endocrinology, central nervous system and anti-viral and anti-infective. Headquartered in Cincinnati, Ohio, Medpace employs approximately 5,800 people across 41 countries.
- Website
-
http://www.medpace.com
External link for Medpace
- Industrie
- Pharmaceutical Manufacturing
- Größe des Unternehmens
- 5,001-10,000 employees
- Hauptsitz
- Cincinnati, OH
- Typ
- Öffentliches Unternehmen
- Gegründet
- 1992
- Spezialitäten
- Early Phase Clinical Research, Phase II-III Clinical Research, RWE-Late Phase Clinical Research, Medical Device and Diagnostics, Regulatory Affairs, Medical Writing, Clinical Monitoring, Clinical Trial Management, Biostatistics and Data Sciences, Drug Safety and Pharmacovigilance, Quality Assurance, Central Laboratories, Bioanalytical Laboratories, Imaging & ECG Core Labs, Oncology clinical development, Nephrology clinical development, Neuroscience clinical development, Infectious Disease clinical development, Cardiovascular clinical development, Metabolic and endocrine clinical development, Rare disease clinical development, Cell and gene therapy clinical development, and Radiopharmaceuticals
Standorte
-
Primäre
5375 Medpace Way
Cincinnati, OH 45227, US
Employees at Medpace
Aktualisierungen
-
Medpace is proud to share that we have been selected as a finalist for the 2024 SCRS Eagle Award! The award recognizes a Sponsor and CRO that demonstrate outstanding leadership, professionalism, integrity, passion, and dedication to advancing clinical research through strong site partnerships. At Medpace, our site relationships are critical to our mission of accelerating the development of safe and effective medical therapeutics. Discover more about our top-performing sites program and site networks today: https://lnkd.in/gSXMVJas #SCRS2024 #SCRSEagleAward
-
-
Our Cincinnati team had the pleasure of visiting the Cincinnati Zoo & Botanical Garden, where we engaged with some of the community's notable residents, including Fiona & Fritz, the hippos, and Kris and Remus, the cheetah and her companion dog. Teams were treated to animal chats and appearances along with Cincinnati cuisine and snacks. Interested in our employee perks and team-building opportunities? Learn more about life at Medpace today: https://bit.ly/3YXZKXq #CincinnatiZoo #WorkAtMedpace #EmployeePerks
-
-
There is a significant unmet need for treatment options for #epilepsy, making it essential to partner with a CRO with specialized expertise to navigate the unique challenges of these trials and accelerate your path to approval. Medpace provides strategic medical, regulatory, and operational experts who are actively involved from project initiation to completion. Our team has a broad range of experience in designing and conducting clinical trials in generalized and focal epilepsy, status epilepticus, Dravet syndrome, Lennox-Gastaut syndrome, Angelman syndrome, infantile spasms, and more. Explore Medpace's comprehensive clinical development capabilities in epilepsy: https://lnkd.in/gDNacefS
-
As students return to campus this fall, the job search is back in full swing. To support students kickstarting their career journey, we spoke with a Medpace recruiter about a crucial first step: networking. Whether you're refining existing skills or starting from scratch, this guide has you covered. Explore tips on how to build or enhance your networking skills today: https://bit.ly/4cxfPGR #Networking #WorkAtMedpace
-
-
The global #cardiovascular community is set to gather in London for the European Society of Cardiology Annual Congress 2024, where they will share transformative research poised to shape the future of cardiovascular medicine. In this edition of Clinical Insights, Medpace Medical Director of Cardiology, Dr Aung Myat MD FACC FESC, explores the latest groundbreaking developments and practice-changing science slated for discussion at this year’s congress. #Subscribe to our newsletter to gain insights into the latest clinical development trends. #MakingTheComplexSeamless #ESC2024
Top 10 Hot Liners at the European Society of Cardiology Annual Congress 2024
Medpace on LinkedIn
-
Medpace is excited to be featured in Realm Cincinnati's article on our upcoming headquarters expansion! Members of leadership discuss details of our growth of not only our office but the area around Madison Square, creating enhanced spaces for employees and community members alike. Read more now: https://bit.ly/3yM1RTG #WorkAtMedpace
Picking Up the Pace at Madison Square - Realm Cincinnati
https://realmcincinnati.com
-
Our latest case study showcases how Medpace’s #oncology experts optimized global trial execution to achieve significant success in a phase III study for renal cell carcinoma by leveraging innovative immuno-oncology therapies. Access the full case study now: https://bit.ly/3LRdZFF Join us at #ESMO24! Schedule a meeting with our oncology experts to discuss this breakthrough and how Medpace can enhance your upcoming oncology projects.
[Case Study] Optimizing Global Immuno-Oncology Trials | Medpace
medpace.com
-
In recent years, rare disease research has shifted significantly, with patients playing an important and proactive role. Recent breakthroughs in rare disease treatment showcases the power of innovation and collaboration between Sponsors, CROs, and patients. Discover key insights into a collaborative approach in #RareDisease drug development by downloading our latest article, "Bridging Gaps in Rare Disease Clinical Trials: Insights from Collaborative Success in Pompe Disease Research": https://lnkd.in/gQcu_wg4
[New Article] Bridging Gaps in Rare Disease Clinical Trials: Insights from Collaborative Success in Pompe Disease Research
medpace.com
-
Last chance to register for this upcoming webinar! Join Medpace experts Amanda Sylvester, Prudence King, and Jennifer Brown as they share how maximizing patient retention and protecting endpoint integrity are making a significant impact on the success of obesity clinical trials. Register now to secure your spot: https://lnkd.in/gAx5JrFs #Obesity #Metabolic #Webinar
-
Ähnliche Seiten
Jobs durchsuchen
Aktie
MEDP
NASDAQ
20 Minuten Verzögerung
$383.36
-1.94 (-0.504%)
- Öffnen Sie
- 382.54
- Niedrig
- 375
- Hoch
- 383.71
Daten von Refinitiv
Siehe mehr Informationen auf